amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
ADDERALL 5 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) by Teva is non-catecholamine sympathomimetic amines with cns stimulant activity. Approved for attention deficit hyperactivity disorder (adhd) in patients 13 years, older [see clinical studies ()], older and 1 more indications. First approved in 1960.
Drug data last refreshed 20h ago · AI intelligence enriched 1w ago
Adderall 5 is an oral tablet containing a mixture of amphetamine salts (amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate) approved since 1960. It is a CNS stimulant indicated for Attention Deficit Hyperactivity Disorder (ADHD) in patients 13 years and older, with a mechanism of action that remains incompletely understood but involves sympathomimetic activity. The drug is also used off-label for insomnia.
As a legacy product with LOE approaching, teams should expect declining market exclusivity, smaller commercial footprint, and focus on transition planning and generic defense strategies.
non-catecholamine sympathomimetic amines with CNS stimulant activity. The exact mode of therapeutic action in ADHD is not known.
Worked on ADDERALL 5 at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on Adderall 5 offers limited career growth potential given its LOE-approaching status and zero linked job openings. Career value is primarily in defensive market management, generic competition navigation, and operational excellence rather than innovation or expansion.